Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Apple
AAPL
|
+$564M |
| 3 |
Amazon
AMZN
|
+$486M |
| 4 |
Meta Platforms (Facebook)
META
|
+$331M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$1.88B |
| 2 |
Alibaba
BABA
|
+$1.21B |
| 3 |
Home Depot
HD
|
+$320M |
| 4 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$274M |
| 5 |
FLIR
FLIR Systems, Inc. (DE) Common Stock
FLIR
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.98% |
| 2 | Financials | 13.87% |
| 3 | Healthcare | 13.39% |
| 4 | Consumer Discretionary | 11.81% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HOFV
3076
DELISTED
Hall of Fame Resort & Entertainment Co
HOFV
| $3.67M | ﹤0.01% |
42,396
+24,688
| +139% | +$2.14M |
|
3077
Universal Logistics Holdings
ULH
$353M
| $3.66M | ﹤0.01% |
156,957
+7,247
| +5% | +$181K |
|
|
OYST
3078
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $3.64M | ﹤0.01% |
211,895
+49,493
| +30% | +$941K |
|
3079
Donegal Group Class A
DGICA
$731M
| $3.64M | ﹤0.01% |
249,963
+33,380
| +15% | +$511K |
|
3080
Tarsus Pharmaceuticals
TARS
$2.58B
| $3.64M | ﹤0.01% |
125,521
+23,712
| +23% | +$741K |
|
3081
Vor Biopharma
VOR
$1.15B
| $3.63M | ﹤0.01% |
9,736
+325
| +3% | +$160K |
|
|
FORA
3082
DELISTED
Forian
FORA
| $3.62M | ﹤0.01% |
288,263
+274,013
| +1,923% | +$3.13M |
|
3083
State Street SPDR S&P 500 ETF Trust
SPY
$795B
| – | – |
0
| – | – |
|
|
EXPR
3084
DELISTED
Express, Inc.
EXPR
| $3.62M | ﹤0.01% |
27,909
-22,920
| -45% | -$1.93M |
|
|
PFBI
3085
DELISTED
Premier Financial Bancorp
PFBI
| $3.61M | ﹤0.01% |
214,365
+9,418
| +5% | +$174K |
|
|
MCBC
3086
DELISTED
Macatawa Bank Corp
MCBC
| $3.61M | ﹤0.01% |
412,701
+31,422
| +8% | +$300K |
|
3087
RELX
RELX
$61.8B
| $3.6M | ﹤0.01% |
134,674
+17,310
| +15% | +$459K |
|
3088
Heritage Insurance Holdings
HRTG
$889M
| $3.6M | ﹤0.01% |
419,872
-4,385
| -1% | -$40.4K |
|
|
JNCE
3089
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $3.6M | ﹤0.01% |
529,515
+186,990
| +55% | +$1.55M |
|
|
CCRD
3090
DELISTED
CoreCard
CCRD
| $3.59M | ﹤0.01% |
114,179
-1,043
| -0.9% | -$37.2K |
|
|
SEEL
3091
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
| $3.59M | ﹤0.01% |
354
+213
| +151% | +$3.5M |
|
3092
Regis Corp
RGS
$68.4M
| $3.59M | ﹤0.01% |
19,184
-110
| -0.6% | -$23.5K |
|
3093
McEwen Inc
MUX
$1.03B
| $3.59M | ﹤0.01% |
259,914
+10,386
| +4% | +$138K |
|
3094
INNOVATE Corp
VATE
$111M
| $3.58M | ﹤0.01% |
90,087
-417
| -0.5% | -$16.9K |
|
|
CSPR
3095
DELISTED
Casper Sleep Inc.
CSPR
| $3.57M | ﹤0.01% |
433,058
+25,083
| +6% | +$219K |
|
|
TAST
3096
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $3.56M | ﹤0.01% |
593,235
+2,085
| +0.4% | +$12.3K |
|
|
BRT
3097
BRT Apartments
BRT
$281M
| $3.56M | ﹤0.01% |
205,233
+15,786
| +8% | +$282K |
|
|
SCWX
3098
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
| $3.56M | ﹤0.01% |
191,863
+19,836
| +12% | +$309K |
|
|
SQZ
3099
DELISTED
SQZ Biotechnologies Company
SQZ
| $3.54M | ﹤0.01% |
245,108
+155,902
| +175% | +$2.04M |
|
3100
Millicom
TIGO
$16B
| $3.52M | ﹤0.01% |
88,871
+2,611
| +3% | +$109K |
|
Similar funds
Geode Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Geode Capital Management held 4,790 positions worth $726B, up 11% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Geode Capital Management's Q2 2021 filing shows 331 new, 3,384 increased, 720 reduced and 74 closed positions. Its largest new stake was Organon & Co: 5,070,121 shares worth $153M. The largest sale was Sherwin-Williams, an estimated $1.88B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q2 2021 buy was Organon & Co: 5,070,121 shares worth $153M.
- Geode Capital Management added most to Microsoft in Q2 2021, an estimated $786M increase.
- Geode Capital Management's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $1.88B.
- Geode Capital Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $274M.
- Geode Capital Management's ten largest holdings make up 22% of its $726B portfolio in Q2 2021.
- Geode Capital Management opened 331 new positions and closed 74 in Q2 2021.
- Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $726B.
Based on Geode Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.